These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 1282774

  • 21. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
    Kawai K, Ando S, Hinotsu S, Oikawa T, Sekido N, Miyanaga N, Shimazui T, Akaza H.
    Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
    [Abstract] [Full Text] [Related]

  • 22. Reduced dose PVB treatment of stage IIC-IV testicular seminoma.
    Berkmen F.
    Eur J Surg Oncol; 1993 Feb; 19(1):24-6. PubMed ID: 7679655
    [Abstract] [Full Text] [Related]

  • 23. Management of good risk germ-cell tumours.
    Troost MM, Sternberg CN, de Wit R.
    BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I, Baki M, Horti J, Géczi L, Liszka G, Ottó S, Hindy I, Eckhardt S, Sugár J.
    Acta Med Hung; 1994 Nov; 50(3-4):275-92. PubMed ID: 8587840
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R, Harada A, Katto K, Yamamoto Y, Kishimoto T, Nakatuji Y, Tanimoto S, Oka N, Izaki H, Fukumori T, Takahashi M, Nishitani M, Kanayama HO.
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I, Ghilezan N.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985 Apr; 34(6):455-68. PubMed ID: 2421373
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC, Pedrosa JA, Kaimakliotis HZ, Masterson TA, Einhorn LH, Foster RS.
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [Abstract] [Full Text] [Related]

  • 38. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C, Auclerc G, Auclerc MF, Verges J, Weil M.
    Prog Clin Biol Res; 1985 Feb; 203():451-6. PubMed ID: 2421336
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.